Diffuse gliomas in adults are now separated into three comprehensive tumor groups with distinctive prognoses, based on the status of isocitrate dehydrogenase genes 1 and 2 (IDH1/2) mutations and 1p/19q-codeletion [1]. The gene discussed is IDH1; the disease is neoplasm.